The subcutaneous implantable cardioverter-defibrillator should be reserved for niche indications
Open Access
- 21 October 2022
- journal article
- editorial
- Published by Elsevier in Heart Rhythm O2
- Vol. 3 (5) , 597-601
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney DiseaseJACC, 2015
- Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter DefibrillatorCirculation, 2013
- Failure of implantable cardioverter-defibrillator leads: A matter of lead size?Heart Rhythm, 2013
- Inappropriate Implantable Cardioverter-Defibrillator ShocksJACC, 2011
- Clinical Predictors of Cardiovascular Implantable Electronic Device‐Related Infective EndocarditisPacing and Clinical Electrophysiology, 2011
- An Entirely Subcutaneous Implantable Cardioverter–DefibrillatorNew England Journal of Medicine, 2010
- Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patientsHeart Rhythm, 2010
- Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 YearsCirculation, 2007
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980